Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder (Q44756641)
Jump to navigation
Jump to search
scientific article published in February 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder |
scientific article published in February 2004 |
Statements
1 reference
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder (English)
1 reference
1 reference
T Rechberger
1 reference
S Al-Shukri
1 reference
P Meffan
1 reference
K Everaert
1 reference
M Huang
1 reference
A Ridder
1 reference
YM-905 Study Group
1 reference
1 February 2004
1 reference
1 reference
93
1 reference
3
1 reference
303-310
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference